API Manufacturing
Large-scale active pharmaceutical ingredient synthesis using cutting-edge chemical engineering and continuous manufacturing platforms.
Learn more →Agarose Scientific is a next-generation pharmaceutical manufacturer delivering high-quality APIs, formulations, and research-backed drug solutions trusted by partners across the globe.
From API synthesis to finished dosage forms — we manage the complete pharmaceutical value chain with precision and compliance.
Large-scale active pharmaceutical ingredient synthesis using cutting-edge chemical engineering and continuous manufacturing platforms.
Learn more →Custom drug formulation across tablets, capsules, injectables, topicals and advanced delivery systems — from prototype to scale.
Learn more →Rigorous multi-stage QC protocols, real-time analytics, and full regulatory documentation ensuring every batch meets global standards.
Learn more →Dedicated research teams exploring novel drug molecules, delivery technologies and generics pipeline with a 42-patent portfolio.
Learn more →Expert regulatory strategy, dossier preparation, and global filing support for FDA, EMA, WHO-PQ, and local health authority submissions.
Learn more →CMO / CDMO services for global pharma brands — flexible capacity, GMP-compliant facilities, and end-to-end supply chain management.
Learn more →Founded in 2000, Agarose Scientific has grown from a regional API manufacturer into a globally trusted pharmaceutical partner — with state-of-the-art facilities and an unwavering commitment to patient wellbeing.
Every compound we develop starts and ends with the patient — quality, safety, and efficacy are non-negotiable.
Operating under USFDA, EMA, and WHO guidelines while maintaining agile, responsive local operations.
Green chemistry principles, zero-waste initiatives, and ISO 14001 environmental management across all facilities.
Targeted therapies and oncological APIs with 12+ active compounds in late-stage development.
Nano-encapsulation, controlled-release, and transdermal patches for enhanced bioavailability.
Bioequivalence studies and ANDA filings enabling affordable global access to essential medicines.
Protein characterization, cell-line development, and biosimilar pathway expertise.
Whether you need contract manufacturing, R&D collaboration, or regulatory support — let's build something remarkable together.
For over 25 years, Agarose Scientific has led pharmaceutical manufacturing with a singular mission: enabling better patient outcomes through precision science and responsible innovation.
To manufacture and deliver high-quality pharmaceutical products that improve human health — with unwavering commitment to safety, efficacy, and ethical responsibility.
To be the world's most trusted pharmaceutical manufacturing partner — pioneering innovations that make life-saving medicines accessible to every corner of the globe.
Integrity in every process. Excellence in every product. Transparency with every partner. Sustainability in every decision. Innovation without compromise.
Agarose Scientific was established in Ahmedabad with a state-of-the-art API manufacturing plant, beginning with 5 core pharmaceutical compounds.
Achieved WHO-GMP certification and commenced export operations to Southeast Asia and African markets — a pivotal milestone in global expansion.
Inaugurated a dedicated 50,000 sq ft Research & Development Centre with over 150 scientists focused on novel formulations and generics pipeline.
Received USFDA approval for our injectable manufacturing facility, enabling entry into the highly regulated US pharmaceutical market.
Launched the Biologics & Biosimilars division, investing ₹500 crore in biopharmaceutical infrastructure to serve the next frontier of medicine.
Recognized as one of India's Top 10 Contract Manufacturing Organizations with 60+ export markets and 1,200+ employees worldwide.
Our manufacturing processes and quality systems are validated and certified by the world's most rigorous regulatory bodies.
World Health Organization Good Manufacturing Practice
United States Food & Drug Administration Approved
European Medicines Agency Compliance
International Quality Management Systems
Environmental Management System Certified
Central Drugs Standard Control Organisation
International Council for Harmonisation Compliant
Pharmaceutical Inspection Co-operation Scheme
Let's discuss how Agarose Scientific can support your pharmaceutical needs.
From molecule to market — Agarose Scientific offers a comprehensive portfolio of pharmaceutical manufacturing, research, and regulatory services tailored for global requirements.
World-class Active Pharmaceutical Ingredient manufacturing using cutting-edge chemistry platforms. Our multi-step synthesis capabilities cover a broad therapeutic spectrum.
State-of-the-art formulation R&D and commercial manufacturing across solid, liquid, and semi-solid dosage forms — built for global regulatory filing.
Comprehensive QC laboratories equipped with advanced analytical instruments ensuring every product batch meets defined specifications.
Experienced regulatory teams navigating complex global submission requirements — reducing time-to-market and maximizing approval probability.
Full-service CDMO solutions — we partner with innovator companies and generic manufacturers to bring their products from development to commercial scale.
End-to-end cold chain and ambient supply chain management ensuring pharmaceutical integrity from our facilities to patients worldwide.
A structured, transparent workflow from client onboarding to final product delivery.
Technical assessment, cost-benefit analysis, and development roadmap planning.
Lab-scale synthesis, formulation trials, and analytical method development.
Dossier preparation, submission management, and regulatory liaison.
Pilot batches, process validation, equipment qualification, and tech transfer.
GMP manufacturing, QC release, packaging, and supply chain deployment.
Our team is ready to discuss your specific pharmaceutical project requirements.
Our multidisciplinary research teams are at the frontier of pharmaceutical science — developing new molecules, improving existing therapies, and pioneering next-generation drug delivery.
Developing targeted oncological APIs including kinase inhibitors, immune checkpoint modulators, and ADC payloads for precision cancer treatment.
12 Active CompoundsNano-encapsulation, liposomal formulations, controlled-release matrices, and transdermal systems optimizing drug bioavailability and patient adherence.
8 Patents FiledBioequivalence study design, formulation strategies for BCS Class II/IV molecules, and comprehensive ANDA filing with proven first-cycle approval rates.
120+ ANDAs FiledCell line development, upstream/downstream bioprocessing, and comprehensive biosimilar comparability studies for monoclonal antibodies and fusion proteins.
5 Biosimilars in PipelineNovel antihypertensives, lipid-lowering agents, and diabetes treatments — addressing the world's leading causes of morbidity with new chemical entities.
3 NCEs in Phase IIResearch into blood-brain barrier-penetrating molecules and innovative approaches to neurodegeneration, anxiety, and psychiatric conditions.
Early Discovery PhaseWe welcome academic, clinical, and industry partnerships to accelerate pharmaceutical innovation.
Our team of 1,200+ professionals — scientists, engineers, regulatory experts, and operational leaders — are united by a passion for advancing human health through pharmaceutical excellence.
We're always looking for passionate scientists, engineers, and professionals who want to make a meaningful difference in global healthcare.
Whether you're looking for a manufacturing partner, exploring research collaboration, or have product inquiries — our team is ready to assist.
We typically respond within 24 business hours.